114 related articles for article (PubMed ID: 38213178)
1. The Pharmacokinetic Interaction of Tirabrutinib with Voriconazole, Itraconazole, and Fluconazole in SD Rats by UPLC-MS/MS.
Xia M; Liu YN; Chen J; Xu RA; Dai G
Curr Med Chem; 2024 Jan; ():. PubMed ID: 38213178
[TBL] [Abstract][Full Text] [Related]
2. UPLC-MS/MS method for the simultaneous determination of imatinib, voriconazole and their metabolites concentrations in rat plasma.
Xu RA; Lin Q; Qiu X; Chen J; Shao Y; Hu G; Lin G
J Pharm Biomed Anal; 2019 Mar; 166():6-12. PubMed ID: 30594035
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of voriconazole, itraconazole and fluconazole on the pharmacokinetic profiles of ivosidenib in rats by UHPLC-MS/MS.
Xie S; Ye L; Ye X; Lin G; Xu RA
J Pharm Biomed Anal; 2020 Aug; 187():113353. PubMed ID: 32417565
[TBL] [Abstract][Full Text] [Related]
4. UPLC-MS/MS determination of voriconazole in human plasma and its application to a pharmacokinetic study.
Wang Z; Huang CK; Sun W; Xiao C; Wang ZS
Biomed Chromatogr; 2015 Feb; 29(2):188-93. PubMed ID: 24925071
[TBL] [Abstract][Full Text] [Related]
5. An LC-MS/MS Bioanalytical Assay for the Determination of Gilteritinib in Rat Plasma and Application to a Drug-Drug Interaction Study.
Wang Q; Chen Z; Chen D; Ye XY
Drug Des Devel Ther; 2020; 14():2061-2067. PubMed ID: 32546970
[TBL] [Abstract][Full Text] [Related]
6. High-throughput identification and determination of antifungal triazoles in human plasma using UPLC-QDa.
Pan L; Fan X; Jia A; Li Y; Zhao Y; Liu Y; Wang A; Ma Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jul; 1226():123774. PubMed ID: 37329778
[TBL] [Abstract][Full Text] [Related]
7. Development of UPLC-MS/MS method for studying the pharmacokinetic interactions of pexidartinib with antifungal drugs in rats.
Shi L; Jiang Z; Zhang B; Tang C; Xu RA
J Pharm Biomed Anal; 2020 Sep; 188():113386. PubMed ID: 32502954
[TBL] [Abstract][Full Text] [Related]
8. The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique.
Wang HJ; Zhou CY; Su YD; Gou KF; Geng XN; Qiu XJ
Drug Des Devel Ther; 2021; 15():4865-4873. PubMed ID: 34876808
[TBL] [Abstract][Full Text] [Related]
9. A rapid UPLC-MS/MS assay for the simultaneous measurement of fluconazole, voriconazole, posaconazole, itraconazole, and hydroxyitraconazole concentrations in serum.
Basu SS; Petrides A; Mason DS; Jarolim P
Clin Chem Lab Med; 2017 May; 55(6):836-844. PubMed ID: 27866173
[TBL] [Abstract][Full Text] [Related]
10. A rapid and sensitive UPLC-MS/MS method for the determination of zanubrutinib in beagle plasma and its application in pharmacokinetics.
Zhu YL; Ding HZ; Gou KF; Sun B; Chen Y; Zhang HW
Biomed Chromatogr; 2023 Jan; 37(1):e5504. PubMed ID: 36094354
[TBL] [Abstract][Full Text] [Related]
11. A Reliable and Effective UPLC-MS/MS Method for the Determination of Oprozomib in Rat Plasma.
Li X; Liu YN; Zhang E; Xu RA; Yang T; Luo S
J Anal Methods Chem; 2023; 2023():3678599. PubMed ID: 37469971
[TBL] [Abstract][Full Text] [Related]
12. A novel bioanalytical method for the quantification of pemigatinib in rat plasma by UPLC-MS/MS.
Weng Q; Tan W; Yu RY; Xu RA; Chen Y
J Pharm Biomed Anal; 2021 Aug; 202():114137. PubMed ID: 34015593
[TBL] [Abstract][Full Text] [Related]
13. Determination of fascaplysin in rat plasma with ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS): application to a pharmacokinetic study.
Hu Z; Zhang M; He M; Fang B; Bao X; Yan X; Liang H; Wang H
J Pharm Biomed Anal; 2019 Jul; 171():126-131. PubMed ID: 30986762
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of a Sensitive, Specific and Reproducible UPLC-MS/MS Method for the Quantification of OJT007, A Novel Anti-Leishmanial Agent: Application to a Pharmacokinetic Study.
Rincon Nigro M; Ma J; Awosemo OT; Xie H; Olaleye OA; Liang D
Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33925369
[TBL] [Abstract][Full Text] [Related]
15. UPLC-MS/MS determination and gender-related pharmacokinetic study of five active ingredients in rat plasma after oral administration of Eucommia cortex extract.
Hu F; An J; Li W; Zhang Z; Chen W; Wang C; Wang Z
J Ethnopharmacol; 2015 Jul; 169():145-55. PubMed ID: 25910535
[TBL] [Abstract][Full Text] [Related]
16. Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats.
Lou Y; Song F; Cheng M; Hu Y; Chai Y; Hu Q; Wang Q; Zhou H; Bao M; Gu J; Zhang Y
PeerJ; 2023; 11():e15844. PubMed ID: 37581117
[TBL] [Abstract][Full Text] [Related]
17. Development of an UPLC-MS/MS Method for the Quantitative Analysis of Upadacitinib in Beagle Dog Plasma and Pharmacokinetics Study.
Wang MJ; Zhao YH; Fan C; Wang YJ; Wang XQ; Qiu XJ; Shen RL
Drug Des Devel Ther; 2021; 15():4167-4175. PubMed ID: 34629864
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous Determination of Rivaroxaban and Enalapril in Rat Plasma by UPLC-MS/MS and Its Application to A Pharmacokinetic Interaction Study.
Zheng S; Luo SB; Mei YB; Guo J; Tong LJ; Zhang Q; Ye XY
Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):229-236. PubMed ID: 30151746
[TBL] [Abstract][Full Text] [Related]
19. Development of a UPLC-MS/MS method for the determination of orelabrutinib in rat plasma and its application in pharmacokinetics.
Liu YN; Hu Y; Wang J; Chen C; Cai J; Xu RA; Lu Z
Front Pharmacol; 2022; 13():991281. PubMed ID: 36147349
[TBL] [Abstract][Full Text] [Related]
20. Effects of voriconazole and fluconazole on the pharmacokinetics of almonertinib in rats by UPLC-MS/MS.
Fu Y; Li Y; Ma Y; He X; Xun X; Cui Y; Fan L; Dong Z
Biomed Chromatogr; 2023 Jan; 37(1):e5525. PubMed ID: 36241418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
